European Journal of Neuroscience · 2006 · 101 citations · 56 references
MedicineNeurobiologyNeuroscienceDevelopmental NeuroscienceNeurochemistryNeuropharmacologyDevelopmental NeuropharmacologyDevelopmental NeurotoxicityGlutamatergic NeurochemistryHypoxic-ischemic Brain InjuryHypoxic-ischemic EncephalopathyNeuroprotectionDevelopmental Neurotoxicity MechanismsExcitotoxic Cell DeathGlutamate-induced NeurotoxicityHippocampal FunctionHippocampal PhysiologyNeonatal Brain IschemiaNeonatal Hypoxic-ischemic EncephalopathyPerinatal Hypoxic-ischemic Encephalopathy
Hypoxic/ischemic (HI) brain injury in newborn full-term and premature infants is a common and pervasive source of life time disabilities in cognitive and locomotor function. In the adult, HI induces glutamate release and excitotoxic cell death dependent on NMDA receptor activation. In animal models of the premature human infant, glutamate is also released following HI, but neurons are largely insensitive to NMDA or AMPA/kainic acid (KA) receptor-mediated damage. Using primary cultured hippocampal neurons we have determined that glutamate increases intracellular calcium much more than kainic acid. Moreover, glutamate induces cell death by activating Type I metabotropic glutamate receptors (mGluRs). Pretreatment of neurons with the gonadal steroid estradiol reduces the level of the Type I metabotropic glutamate receptors and completely prevents cell death, suggesting a novel therapeutic approach to excitotoxic brain damage in the neonate.
56
Glutamate neurotoxicity and diseases of the nervous system
Dennis W. Choi · Neuron · 1988 · 8K citations
Cerebral hypoxia: some new approaches and unanswered questions
DW Choi · Journal of Neuroscience · 1990 · 674 citations · Full text
Medicine, Neurology, Neuroscience +17